Literature DB >> 31801909

Discovery of specialized NK cell populations infiltrating human melanoma metastases.

Lucas Ferrari de Andrade1,2,3, Yuheng Lu4, Adrienne Luoma1,2, Yoshinaga Ito1,2, Deng Pan1,2, Jason W Pyrdol1, Charles H Yoon5,6, Guo-Cheng Yuan4,7, Kai W Wucherpfennig1,2.   

Abstract

NK cells contribute to protective antitumor immunity, but little is known about the functional states of NK cells in human solid tumors. To address this issue, we performed single-cell RNA-seq analysis of NK cells isolated from human melanoma metastases, including lesions from patients who had progressed following checkpoint blockade. This analysis identified major differences in the transcriptional programs of tumor-infiltrating compared with circulating NK cells. Tumor-infiltrating NK cells represented 7 clusters with distinct gene expression programs indicative of significant functional specialization, including cytotoxicity and chemokine synthesis programs. In particular, NK cells from 3 clusters expressed high levels of XCL1 and XCL2, which encode 2 chemokines known to recruit XCR1+ cross-presenting DCs into tumors. In contrast, NK cells from 2 other clusters showed a higher level of expression of cytotoxicity genes. These data reveal key features of NK cells in human tumors and identify NK cell populations with specialized gene expression programs.

Entities:  

Keywords:  Immunology; Innate immunity; Melanoma; NK cells; Oncology

Year:  2019        PMID: 31801909      PMCID: PMC6962021          DOI: 10.1172/jci.insight.133103

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  25 in total

1.  Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.

Authors:  Yonit Lavin; Soma Kobayashi; Andrew Leader; El-Ad David Amir; Naama Elefant; Camille Bigenwald; Romain Remark; Robert Sweeney; Christian D Becker; Jacob H Levine; Klaus Meinhof; Andrew Chow; Seunghee Kim-Shulze; Andrea Wolf; Chiara Medaglia; Hanjie Li; Julie A Rytlewski; Ryan O Emerson; Alexander Solovyov; Benjamin D Greenbaum; Catherine Sanders; Marissa Vignali; Mary Beth Beasley; Raja Flores; Sacha Gnjatic; Dana Pe'er; Adeeb Rahman; Ido Amit; Miriam Merad
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

2.  Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab.

Authors:  Yoshinobu Koguchi; Helena M Hoen; Shelly A Bambina; Michael D Rynning; Richard K Fuerstenberg; Brendan D Curti; Walter J Urba; Christina Milburn; Frances Rena Bahjat; Alan J Korman; Keith S Bahjat
Journal:  Cancer Res       Date:  2015-12-01       Impact factor: 12.701

3.  Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.

Authors:  Qing Zhang; Jiacheng Bi; Xiaodong Zheng; Yongyan Chen; Hua Wang; Wenyong Wu; Zhengguang Wang; Qiang Wu; Hui Peng; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  Nat Immunol       Date:  2018-06-18       Impact factor: 25.606

4.  Tumor cells of non-hematopoietic and hematopoietic origins express activation-induced C-type lectin, the ligand for killer cell lectin-like receptor F1.

Authors:  Akinobu Akatsuka; Masayuki Ito; Chisako Yamauchi; Atsushi Ochiai; Kazuo Yamamoto; Naoki Matsumoto
Journal:  Int Immunol       Date:  2010-07-26       Impact factor: 4.823

5.  Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.

Authors:  Armando M Marrufo; Stephen O Mathew; Pankaj Chaudhary; Joseph D Malaer; Jamboor K Vishwanatha; Porunelloor A Mathew
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

Review 6.  Chemokines in cancer.

Authors:  Melvyn T Chow; Andrew D Luster
Journal:  Cancer Immunol Res       Date:  2014-12       Impact factor: 11.151

Review 7.  Targeting natural killer cells in cancer immunotherapy.

Authors:  Camille Guillerey; Nicholas D Huntington; Mark J Smyth
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

8.  First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.

Authors:  Rizwan Romee; Sarah Cooley; Melissa M Berrien-Elliott; Peter Westervelt; Michael R Verneris; John E Wagner; Daniel J Weisdorf; Bruce R Blazar; Celalettin Ustun; Todd E DeFor; Sithara Vivek; Lindsey Peck; John F DiPersio; Amanda F Cashen; Rachel Kyllo; Amy Musiek; András Schaffer; Milan J Anadkat; Ilana Rosman; Daniel Miller; Jack O Egan; Emily K Jeng; Amy Rock; Hing C Wong; Todd A Fehniger; Jeffrey S Miller
Journal:  Blood       Date:  2018-02-20       Impact factor: 25.476

9.  High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice.

Authors:  Adeline Crinier; Pierre Milpied; Bertrand Escalière; Christelle Piperoglou; Justine Galluso; Anaïs Balsamo; Lionel Spinelli; Inaki Cervera-Marzal; Mikaël Ebbo; Mathilde Girard-Madoux; Sébastien Jaeger; Emilie Bollon; Sami Hamed; Jean Hardwigsen; Sophie Ugolini; Frédéric Vély; Emilie Narni-Mancinelli; Eric Vivier
Journal:  Immunity       Date:  2018-11-06       Impact factor: 31.745

10.  SCENIC: single-cell regulatory network inference and clustering.

Authors:  Sara Aibar; Carmen Bravo González-Blas; Thomas Moerman; Vân Anh Huynh-Thu; Hana Imrichova; Gert Hulselmans; Florian Rambow; Jean-Christophe Marine; Pierre Geurts; Jan Aerts; Joost van den Oord; Zeynep Kalender Atak; Jasper Wouters; Stein Aerts
Journal:  Nat Methods       Date:  2017-10-09       Impact factor: 28.547

View more
  20 in total

1.  Enhanced development of functional human NK cells in NOD-scid-IL2rgnull mice expressing human IL15.

Authors:  Ken-Edwin Aryee; Lisa M Burzenski; Li-Chin Yao; James G Keck; Dale L Greiner; Leonard D Shultz; Michael A Brehm
Journal:  FASEB J       Date:  2022-09       Impact factor: 5.834

2.  Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy.

Authors:  Jiannong Li; Inna Smalley; Zhihua Chen; Jheng-Yu Wu; Manali S Phadke; Jamie K Teer; Thanh Nguyen; Florian A Karreth; John M Koomen; Amod A Sarnaik; Jonathan S Zager; Nikhil I Khushalani; Ahmad A Tarhini; Vernon K Sondak; Paulo C Rodriguez; Jane L Messina; Y Ann Chen; Keiran S M Smalley
Journal:  Clin Cancer Res       Date:  2022-05-13       Impact factor: 13.801

3.  Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in BrafV600E/PtenNULL Mice.

Authors:  Gagan Chhabra; Chandra K Singh; Glorimar Guzmán-Pérez; Mary A Ndiaye; Kenneth A Iczkowski; Nihal Ahmad
Journal:  J Invest Dermatol       Date:  2021-09-29       Impact factor: 7.590

4.  Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells.

Authors:  Ying Yang; Shi Yong Neo; Ziqing Chen; Weiyingqi Cui; Yi Chen; Min Guo; Yongfang Wang; Haiyan Xu; Annina Kurzay; Evren Alici; Lars Holmgren; Felix Haglund; Kai Wang; Andreas Lundqvist
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 5.  Melanoma models for the next generation of therapies.

Authors:  E Elizabeth Patton; Kristen L Mueller; David J Adams; Niroshana Anandasabapathy; Andrew E Aplin; Corine Bertolotto; Marcus Bosenberg; Craig J Ceol; Christin E Burd; Ping Chi; Meenhard Herlyn; Sheri L Holmen; Florian A Karreth; Charles K Kaufman; Shaheen Khan; Sebastian Kobold; Eleonora Leucci; Carmit Levy; David B Lombard; Amanda W Lund; Kerrie L Marie; Jean-Christophe Marine; Richard Marais; Martin McMahon; Carla Daniela Robles-Espinoza; Ze'ev A Ronai; Yardena Samuels; Maria S Soengas; Jessie Villanueva; Ashani T Weeraratna; Richard M White; Iwei Yeh; Jiyue Zhu; Leonard I Zon; Marc S Hurlbert; Glenn Merlino
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

6.  Memory-like Differentiation Enhances NK Cell Responses to Melanoma.

Authors:  Nancy D Marin; Bradley A Krasnick; Michelle Becker-Hapak; Leah Conant; Simon P Goedegebuure; Melissa M Berrien-Elliott; Keenan J Robbins; Jennifer A Foltz; Mark Foster; Pamela Wong; Celia C Cubitt; Jennifer Tran; Christopher B Wetzel; Miriam Jacobs; Alice Y Zhou; David Russler-Germain; Lynne Marsala; Timothy Schappe; Ryan C Fields; Todd A Fehniger
Journal:  Clin Cancer Res       Date:  2021-06-29       Impact factor: 12.531

7.  Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment.

Authors:  Uriel Y Moreno-Nieves; Joshua K Tay; Saumyaa Saumyaa; Nina B Horowitz; June Ho Shin; Imran A Mohammad; Bogdan Luca; David C Mundy; Gunsagar S Gulati; Nikita Bedi; Serena Chang; Chen Chen; Michael J Kaplan; Eben L Rosenthal; F Christopher Holsinger; Vasu Divi; Fred M Baik; Davud B Sirjani; Andrew J Gentles; Aaron M Newman; Aharon G Freud; John B Sunwoo
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

Review 8.  The Adverse Impact of Tumor Microenvironment on NK-Cell.

Authors:  Ziming Hu; Xiuxiu Xu; Haiming Wei
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

Review 9.  Anesthesia Options and the Recurrence of Cancer: What We Know so Far?

Authors:  Juan P Cata; Carlos Guerra; German Soto; Maria F Ramirez
Journal:  Local Reg Anesth       Date:  2020-07-07

Review 10.  Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors.

Authors:  Lara Gibellini; Sara De Biasi; Camillo Porta; Domenico Lo Tartaro; Roberta Depenni; Giovanni Pellacani; Roberto Sabbatini; Andrea Cossarizza
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.